Immature Platelets and Platelet Reactivity in Patients with COVID-19
Coronavirus disease 2019 (COVID-19) is associated with a high incidence of thromboembolic events, both venous and arterial. There are currently no specific clinical or laboratory markers to guide antithrombotic therapy for COVID-19 patients. Immature platelets represent a population of hyper-reactiv...
Saved in:
| Main Authors: | Yulia Balmakov BMSc, Tomer Mark MD, Itzik Barnett MHA, Michal Cipok PHD, Eli I. Lev MD, Amir Cohen MD, Eliad Aviram MD, MHA, Ami Mayo MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-02-01
|
| Series: | Clinical and Applied Thrombosis/Hemostasis |
| Online Access: | https://doi.org/10.1177/10760296251318320 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From reticulated platelets to immature platelet fraction: structure, function, and clinical applications
by: Yuxin Zhang, et al.
Published: (2025-12-01) -
Platelet-Rich Plasma Injection for Painful Trapeziometacarpal Osteoarthritis
by: Kajsa Evans, MD, et al.
Published: (2025-06-01) -
Immature platelet fraction in patients diagnosed with COVID-19
by: Neha Parashar, et al.
Published: (2025-04-01) -
Selected and Gene Polymorphisms in Patients with Migraine and Sticky Platelet Syndrome
by: Tomas Simurda MD, PhD, et al.
Published: (2025-07-01) -
Efficacy of Combined Use of PELNAC and Platelet-rich Plasma in Promoting Wound Healing
by: Hiroshi Fujimaki, MD, PhD, et al.
Published: (2025-08-01)